Literature DB >> 33585540

Case Report: Nutritional Examination of Weight Loss Treatment Using Kampo.

Yutaka Matsui1, Ikuko Matsui1.   

Abstract

Loss of appetite is a common symptom in patients with dementia, and if weight loss or difficulty eating occurs without subjective symptoms, the patient can easily become malnourished. There is also a close relationship between dementia and physical frailty, such as weight loss and muscle weakness, and thus early intervention to address frailty in patients with dementia is important. In this study, 3 patients with dementia who complained of loss of appetite and weight loss showed increases in body weight and muscle mass after taking Ninjin'yoeito. Ninjin'yoeito was found to be a potentially effective treatment option for physical frailty in patients with dementia.
Copyright © 2021 Matsui and Matsui.

Entities:  

Keywords:  Ninjin'yoeito; dementia; loss of appetite; muscle mass; weight loss

Year:  2021        PMID: 33585540      PMCID: PMC7873350          DOI: 10.3389/fnut.2021.551373

Source DB:  PubMed          Journal:  Front Nutr        ISSN: 2296-861X


  5 in total

1.  Ninjin-yoeito activates ghrelin-responsive and unresponsive NPY neurons in the arcuate nucleus and counteracts cisplatin-induced anorexia.

Authors:  Chayon Goswami; Katsuya Dezaki; Lei Wang; Akio Inui; Yutaka Seino; Toshihiko Yada
Journal:  Neuropeptides       Date:  2019-03-06       Impact factor: 3.286

2.  Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.

Authors:  Hiroshi Takeda; Chiharu Sadakane; Tomohisa Hattori; Takehiko Katsurada; Tatsuya Ohkawara; Koichi Nagai; Masahiro Asaka
Journal:  Gastroenterology       Date:  2008-02-29       Impact factor: 22.682

3.  Prospective longitudinal study of frailty transitions in a community-dwelling cohort of older adults with cognitive impairment.

Authors:  Mei Sian Chong; Laura Tay; Mark Chan; Wee Shiong Lim; Ruijing Ye; Eng King Tan; Yew Yoong Ding
Journal:  BMC Geriatr       Date:  2015-12-29       Impact factor: 3.921

4.  A Clinical Study of Ninjin'yoeito With Regard to Frailty.

Authors:  Naoya Sakisaka; Kazuo Mitani; Sadahiro Sempuku; Tamaki Imai; Yoshinori Takemoto; Hiroaki Shimomura; Takahisa Ushiroyama
Journal:  Front Nutr       Date:  2018-09-24

Review 5.  Perspectives on the Use of Ninjin'yoeito in Modern Medicine: A Review of Randomized Controlled Trials.

Authors:  Shin Takayama; Ryutaro Arita; Minoru Ohsawa; Akiko Kikuchi; Hiromichi Yasui; Toshiaki Makino; Yoshiharu Motoo; Tadashi Ishii
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-02       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.